Efficacy of topical hyaluronic acid for symptomatic oral lichen planus: A systematic Review.


Background: Oral lichen planus (OLP) is a chronic inflammatory disorder with a potential of malignant transformation. Despite the extensive research on the topic, the management of OLP is still quite challenging, with no definitive cure. Objective: The present systematic review assessed the efficacy of topical hyaluronic acid in the management of OLP. Material and Methods: A comprehensive search of PubMed, Scopus, Web of Science and Google Scholar was carried out by two independent investigators. All randomized clinical trials that compared the efficacy of hyaluronic acid with other interventions and/or placebo in the management of OLP and fulfilled the following criteria were included: 1) OLP diagnosis was confirmed clinically and histopathologically, 2) the study included systemically healthy patients aged 15 years and older, 3) a minimum sample size of 10, and 4) reporting the main outcomes including pain, erythema, and ulcer size. Case reports, case series, reviews, animal studies, uncontrolled trials were excluded. Results: Four clinical trials involving 234 patients were included. Two studies compared hyaluronic acid with a topical corticosteroid, and two studies compared it with placebo. Only one of the four included studies was at low risk of bias. Overall, topical hyaluronic acid showed good efficacy in alleviating the signs and symptoms of OLP. Two studies found hyaluronic acid significantly more effective in reducing pain and improving clinical signs of OLP compared to placebo. Compared to topical corticosteroids, one study reported comparable results; and one study found hyaluronic acid to be superior to triamcinolone in reducing pain but inferior to triamcinolone in improving the healing time. Conclusion: The limited available evidence suggests that hyaluronic acid may have some benefits in the management of OLP. Further well-designed studies with adequate follow-up periods are highly recommended.


[1]. Carrozzo M, Porter S, Mercadante V, Fedele S Oral lichen planus: A disease or a spectrum of tissue reactions? Types, causes, diagnostic algorithms, prognosis, management strategies. Periodontol 2000. 2019;80:105-25.

[2]. Al-Maweri SA, Al-Jamaei A, Saini R, Laronde DM, Sharhan A White oral mucosal lesions among the Yemeni population and their relation to local oral habits. J Investig Clin Dent. 2018;9:e12305.

[3]. González-Moles M, Warnakulasuriya S, González-Ruiz I, González-Ruiz L, Ayén Á, Lenouvel D, et al. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2020.

[4]. Alaizari NA, Al-Maweri SA, Al-Shamiri HM, Tarakji B, Shugaa-Addin B Hepatitis C virus infections in oral lichen planus: a systematic review and meta-analysis. Aust Dent J. 2016;61:282-7.

[5]. DeAngelis LM, Cirillo N, McCullough MJ The immunopathogenesis of oral lichen planus—Is there a role for mucosal associated invariant T cells? Journal of Oral Pathology & Medicine. 2019;48:552-9.

[6]. Saini R, Al-Maweri SA, Saini D, Ismail NM, Ismail AR Oral mucosal lesions in non oral habit diabetic patients and association of diabetes mellitus with oral precancerous lesions. Diabetes Res Clin Pract. 2010;89:320-6.

[7]. Ashraf S, Al-Maweri SA, Alaizari N, Umair A, Ariffin Z, Alhajj MN, Kassim S, Awan KH. The association between Epstein-Barr virus and oral lichen planus: A systematic review and meta-analysis. J Oral Pathol Med. 2020;49(10):969-76.

[8]. Nolan A, Badminton J, Maguire J, Seymour RA The efficacy of topical hyaluronic acid in the management of oral lichen planus. J Oral Pathol Med. 2009;38:299-303.

[9]. González-Moles M, Ruiz-Ávila I, González-Ruiz L, Ayén Á, Gil-Montoya JA, Ramos-García P Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis. Oral Oncol. 2019;96:121-30.

[10]. Hashem AS, Issrani R, Elsayed TEE, Prabhu N Topical hyaluronic acid in the management of oral lichen planus: A comparative study. J Investig Clin Dent. 2019;10:e12385.

[11]. Al-Maweri SA, Ashraf S, Kalakonda B, Halboub E, Petro W, AlAizari NA Efficacy of photodynamic therapy in the treatment of symptomatic oral lichen planus: A systematic review. J Oral Pathol Med. 2018;47:326-32.

[12]. Yang H, Wu Y, Ma H, Jiang L, Zeng X, Dan H, Zhou Y, Chen Q. Possible alternative therapies for oral lichen planus cases refractory to steroid therapies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(5):496-509.

[13]. Al-Maweri SA, Kalakonda B, Al-Soneidar WA, Al-Shamiri HM, Alakhali MS, Alaizari N Efficacy of low-level laser therapy in management of symptomatic oral lichen planus: a systematic review. Lasers Med Sci. 2017;32:1429-37.

[14]. Vasvani S, Kulkarni P, Rawtani D Hyaluronic acid: a review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies. International journal of biological macromolecules. 2020;151:1012-29.

[15]. Graça MFP, Miguel SP, Cabral CSD, Correia IJ Hyaluronic acid-Based wound dressings: A review. Carbohydr Polym. 2020;241:116364.

[16]. Bronstone A, Neary JT, Lambert TH, Dasa V Supartz (Sodium Hyaluronate) for the Treatment of Knee Osteoarthritis: A Review of Efficacy and Safety. Clin Med Insights Arthritis Musculoskelet Disord. 2019;12:1179544119835221.

[17]. Chen LH, Xue JF, Zheng ZY, Shuhaidi M, Thu HE, Hussain Z Hyaluronic acid, an efficient biomacromolecule for treatment of inflammatory skin and joint diseases: A review of recent developments and critical appraisal of preclinical and clinical investigations. Int J Biol Macromol. 2018;116:572-84.

[18]. Yasuda T Hyaluronan inhibits prostaglandin E2 production via CD44 in U937 human macrophages. Tohoku J Exp Med. 2010;220:229-35.

[19]. Iturriaga V, Bornhardt T, Manterola C, Brebi P Effect of hyaluronic acid on the regulation of inflammatory mediators in osteoarthritis of the temporomandibular joint: a systematic review. Int J Oral Maxillofac Surg. 2017;46:590-5.

[20]. Casale M, Moffa A, Vella P, Rinaldi V, Lopez MA, Grimaldi V, et al. Systematic review: the efficacy of topical hyaluronic acid on oral ulcers. J Biol Regul Homeost Agents. 2017;31:63-9.

[21]. Youssef MI, Darwish ZE, Fahmy RA, El Sayed NM The effect of topically applied hyaluronic acid gel versus topical corticosteroid in the treatment of erosive oral lichen planus. Alexandria Dental Journal. 2019;44:57-63.

[22]. Shetty RR, Burde KN, Guttal KS The Efficacy of Topical Hyaluronic Acid 0.2% in the Management of Symptomatic Oral Lichen Planus. J Clin Diagn Res. 2016;10:Zc46-50.

[23]. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.

[24]. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG; Consolidated Standards of Reporting Trials Group. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):e1-37

[25]. Kumahashi N, Naitou K, Nishi H, Oae K, Watanabe Y, Kuwata S, Ochi M, Ikeda M, Uchio Y. Correlation of changes in pain intensity with synovial fluid adenosine triphosphate levels after treatment of patients with osteoarthritis of the knee with high-molecular-weight hyaluronic acid. Knee. 2011;18(3):160-4.

[26]. Chen CP, Hung W, Lin SH. Effectiveness of hyaluronic acid for treating diabetic foot: a systematic review and meta-analysis. Dermatol Ther. 2014;27(6):331-6.
How to Cite
AL-MAWERI, Sadeq A. et al. Efficacy of topical hyaluronic acid for symptomatic oral lichen planus: A systematic Review.. Journal of Oral Research, [S.l.], v. 10, n. 4, p. 1-7, aug. 2021. ISSN 0719-2479. Available at: <https://www.joralres.com/index.php/JOralRes/article/view/joralres.2021.056>. Date accessed: 19 may 2024. doi: https://doi.org/10.17126/joralres.2021.056.